R&D Reinforcement

A continued increase in R&D investment (9.1% of sales invested) More than 900 new drugs on the pipeline stage

The Korean pharmaceutical industry continues to expand its investment in R&D each year to boost the development of new medicines. Korean pharmaceutical companies have more than 900 new medicines currently in the pipeline and this number accounts for 4% of the total pipelines in the world.

R&D Investment

About USD 2 billion each year invested to
promote the pharmaceutical industry.

2008 3.8% 2015 9.1%
Pipeline Investment

Pipeline investment of domestic pharmaceutical
companies to develop new drugs

908Cases and more
Source: Health Industry Trends-September 2014(Korea Health Industry Development Institute) & Global data(2017)